Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1142820210050020029
Bio, Ethics and Policy
2021 Volume.5 No. 2 p.29 ~ p.48
Pediatric Vaccination of COVID-19 Vaccine: What Should We Prepare?
Park So-Youn

Abstract
More than a year and a half has passed since the WHO declared the COVID-19 pandemic on March 11, 2020. Contrary to the initial expectation that the situation would end soon, people have to still comply with safety and quarantine guidelines, such as wearing a mask and social distancing. Experts have predicted that the COVID-19 situation will end when approximately two-thirds of the population acquire immunity, and one of the most effective means of achieving is vaccination. However, as mutations of the virus, such as the Delta variant, have continued to evolve, breakthrough infections are crucial in changing existing policies. This paper aims to identify the disease burden among children with regard to COVID-19 breakthrough infections and review the issues that should be considered for future policy approach to the vaccination of children who have been excluded from the existing vaccine policy in South Korea. Therefore, we determined the demand and necessity for pediatric vaccination and the public perception-related factors for refusing or accepting vaccination. In addition, the ethical issues that should first be considered, such as safety, impact on normal development, and the dimensions of clinical trials, were examined in relation to establishing vaccination policies for children in South Korea. We found that the government¡¯s timely and clear communication is essential in building public trust.
KEYWORD
COVID-19, pediatrics, vaccination, immunity, risk communication, health policy
FullTexts / Linksout information
Listed journal information